November 03, 2022
Targovax ASA: Third quarter 2022 results
Media
November 01, 2022
Carisma Therapeutics Announces Multiple Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer 37th Anniversary Annual Meeting
October 27, 2022
BONESUPPORT HOLDING AB (publ) – Publishes Q3 2022 interim report
October 27, 2022
Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership
October 26, 2022
Oncopeptides phase 3 LIGHTHOUSE study further confirms clinical benefit of melflufen
October 24, 2022
BONESUPPORT’s CERAMENT®G used in first U.S. patient cases
October 20, 2022
Issue and re-purchase of class C shares for shareholder program and incentive program
October 20, 2022
The ONCOS-102 phase 1b melanoma study is published in the prestigious scientific journal Clinical Cancer Research – with updated publication info
October 12, 2022
Vicore selects new ATRAG as next Drug Candidate
October 06, 2022
Vicore’s digital therapeutic for IPF patients shows nearly 50% anxiety reduction in pilot study